slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 231,841-231,870
Pages 10,126
Rows per page 30
Component
231,841-231,870 of 303,780
30
The slide provides key performance indicators and structural details for the Middle Market segment of Main Street Capital's portfolio.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
31
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
32
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
34
The 2023 data points are highlighted in green, indicating the most recent fiscal year.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Financials1 hit
35
The chart uses a combination of bar and line graphs to illustrate long-term financial performance.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Financials1 hit
36
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Financials1 hit
37
The chart highlights MAIN's cost efficiency by showing both total and non-cash compensation-adjusted expense ratios.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · FinancialsLoop · Benchmark Gap1 hit
38
Includes footnotes regarding non-GAAP disclosures and calculation methodologies.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · FinancialsLoop · Benchmark Gap1 hit
39
The table tracks the bridge from beginning NAV to ending NAV per share, accounting for income, expenses, gains/losses, dividends, and share offerings.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Financials1 hit
40
Includes footnotes regarding credit facilities and notes payable details.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Financials1 hit
41
Includes detailed footnotes explaining debt components and ratio calculation methodologies.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Financials1 hit
42
The slide highlights a conservative capital structure with a mix of secured floating-rate and unsecured fixed-rate debt.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Financials1 hit
43
The chart illustrates the staggered maturity profile of various debt instruments including SBIC debentures, Credit Facilities, and various Notes.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Financials1 hit
44
The slide details the impact of interest rate fluctuations on net investment income, highlighting the company's fixed-rate debt and floating-rate investment portfolio with interest rate floors.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Financials1 hit
45
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
46
The chart highlights specific market periods: 'Recessionary Period' (2008-2009) and 'COVID Pandemic Period' (2020-2021).Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
47
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
48
Standard financial disclosure slide for non-GAAP metrics.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
49
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
02
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations 1 hit
03
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Loop · Golden Circle1 hit
04
The slide uses a combination of molecular diagrams and bulleted lists to explain the mechanism and benefits of the LNC technology.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations 1 hit
05
The slide uses a biological mechanism of action (MOA) framework to describe how LNCs (lipid nanocochleates) utilize PS to target cells.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations 1 hit
07
The slide uses a 'media montage' approach to establish urgency and external validation of the problem.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
Uses a 'Before-After-Bridge' style logic to frame the drug's value proposition.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide displays the header and author list of a published medical journal article.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Loop · Cost Of Inaction1 hit
11
The slide uses a human silhouette as a central anchor to map specific fungal pathogens to their corresponding infection sites in the body.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Loop · Cost Of Inaction1 hit
12
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Loop · Cost Of Inaction1 hit
13
Includes a timeline diagram and two line charts tracking Creatinine and Potassium levels over time.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Loop · Cost Of Inaction1 hit
14
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Loop · Cost Of Inaction1 hit